Company: GMRE
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001104659-25-110926
Chunk: 60

Company: Global Medical REIT Inc.
Filing Date: 2025-11-13
Form: 424B5
Chunk 60
---

entitled to cast not less than two-thirds of all the votes to be cast on the matter) and certain amendments that require, pursuant to
the MGCL, only approval by our board of directors, these actions may be taken only if advised by our board of directors and approved by
the affirmative vote of stockholders entitled to cast a majority of all the votes entitled to be cast on the matter.

Listing. Our common stock is currently
listed on the NYSE under the symbol “GMRE.”

Transfer Agent and Registrar. The transfer
agent and registrar for our common stock is American Stock Transfer & Trust Company, LLC.

| 8 |

Description of Series A Preferred Stock

Our charter provides that we may issue up to 10,000,000
shares of preferred stock, $0.001 par value per share. 3,105,000 shares of preferred stock have been designated as shares of 7.50% Series
A Cumulative Redeemable Preferred Stock, par value $0.001 per share. As of February 26, 2024, there were 3,105,000 shares of our Series
A Preferred Stock issued and outstanding. Our charter authorizes the board of directors to amend our charter to increase or decrease the
aggregate number of authorized shares or the number of shares of any class or series without stockholder approval. Our board of directors
may authorize the issuance of preferred stock in one or more classes or series and may determine, with respect to any such class or series,
the rights, preferences, privileges and restrictions of the preferred stock of that class or series.

Reopening. The provisions of our charter
establishing our Series A Preferred Stock permit us to “reopen” this series, without the consent of the holders of our Series
A Preferred Stock, in order to issue additional shares of Series A Preferred Stock from time to time. We may in the future issue additional
shares of Series A Preferred Stock without the consent of the holders of Series A Preferred Stock. Any additional shares of Series A Preferred
Stock will have the same terms as our current Series A Preferred Stock. These additional shares of Series A Preferred Stock will, together
with our current Series A Preferred Stock, constitute a single series of securities.

Maturity. Our Series A Preferred Stock
has no stated maturity and is not subject to any sinking fund or mandatory redemption, and will remain outstanding indefinitely unless
and until (i) we redeem such Series A Preferred Stock at our option as described below in “— Redemption at